Olivia Brayer

What data did you submit to the FDA for the less restrictive camsiosrans? Did that include anything additional versus what was submitted

where is that confidence coming from? I'm assuming you're seeing some good growth in April trends? And then how long do you actually expect that sequential growth to continue

how quickly do you actually think you can enroll some of those studies like PAH in particular?

Can you comment at all on the scripts trends that SYMPHONY is picking up? Are those January and early February trends indicative of what you guys are seeing on your end?

can you just comment on the decision to keep that the same in Europe versus the U.S.?

whether there will be quantity limits or any other utilization management parameters put in place for JOURNAVX